Corneal striae in thyroid eye disease

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Contralateral Eye Study Comparing Corneal Biomechanics in Subjects with Bilateral Keratoconus with Unilateral Vogt’s Striae

The aim of this study was to analyze and compare corneal biomechanics in patients with bilateral keratoconus (KCN) with unilateral Vogt's striae. In this prospective contralateral study, visual acuity, refraction, and corneal biomechanical parameters were evaluated in patients with bilateral KCN with unilateral Vogt's striae using the Ocular Response Analyzer (ORA) (Reichert Inc., Buffalo, NY) ...

متن کامل

Thyroid eye disease.

Most patients receive conservative treatment — lubrication of the eye to reduce symptoms related to disturbance of the tear film. About 5% of patients will need more aggressive therapy (e.g., systemic corticosteroids, orbital radiation, surgical removal of orbital walls) to prevent vision loss caused by either compression of the optic nerve by enlarging extraocular muscles or corneal ulceration...

متن کامل

Thyroid Eye Disease

Treatment ........................................................... 16  Introduction to treatment ................................ 16  Management of systemic hyperthyroidism...... 17  Overview of treatment options ....................... 20 o Corticosteroids .......................................... 20 o Orbital radiotherapy .................................. 20 o Selenium ..................

متن کامل

Thyroid Eye Disease

Management is challenging and requires a team approach. Medical management is only available in the active, early phase. When the disease becomes inactive (no acute inflammation), surgery is the only option. TED is sight-threatening in up to 5% of patients, although most cases are mild and self-limiting. [1]See also separate articles Thyroid Function Tests, Hyperthyroidism, Hyperthyroidism in P...

متن کامل

Rituximab for thyroid eye disease.

PURPOSE To assess the efficacy and safety of rituximab-mediated B-lymphocyte depletion as treatment for thyroid eye disease (TED). METHODS Prospective, open-label, interventional clinical trial evaluating 12 patients with TED and Clinical Activity Scores (CAS) (VISA [vision, inflammation, strabismus and appearance/exposure] classification) of 4 or greater followed for 1 year after rituximab (...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Eye

سال: 2007

ISSN: 0950-222X,1476-5454

DOI: 10.1038/sj.eye.6702740